Search for: "Ortho-McNeil Janssen Pharmaceuticals Inc" Results 21 - 40 of 74
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
27 Jul 2012, 12:40 pm by Bexis
Cephalon, Inc., 2010 WL 1257790, at *6 (D.N.J. [read post]
17 Feb 2012, 11:29 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
26 Dec 2011, 1:02 am by Victoria VanBuren
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
3 Oct 2011, 9:28 pm by Barry Barnett
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 11-2070 (7th Cir. [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
A South Carolina judge has ordered Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit to pay the state of South Carolina $327 million for deceptive marketing of their anti-psychotic drug, Risperdal. [read post]
5 Jul 2011, 11:13 pm
One of J&J's lawyers said, “The jury took a good, hard look at all the evidence and correctly concluded that Ortho-McNeil-Janssen Pharmaceuticals, Inc. acted responsibly and properly in disclosing the risks associated with this effective and life-saving medicine. [read post]
21 Jun 2011, 6:00 am by Mark Zamora
Ortho-McNeil-Janssen Pharmaceuticals Inc. announced that the lot of about 16,000 bottles of 3-milligram Risperdal tablets was shipped out anywhere from August, 2010  and February, 2011. [read post]
20 Jun 2011, 7:47 am by info@thomasjhenrylaw.com
Ortho-McNeil-Janssen Pharmaceuticals, Inc., a member of the Johnson and Johnson family, has issued a recall of about 40,000 bottles of Risperdal and its generic form. [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
Paliperidone FDA approved INVEGA on December 19, 2006 under NDA No. 21-999 and granted the sponsor, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
23 May 2011, 9:59 pm by Patent Docs
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release… [read post]
18 Apr 2011, 1:12 pm by Mark Zamora
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. [read post]
18 Apr 2011, 12:40 pm by Tom Lamb
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side… [read post]